Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Aug 14, 2018

SELL
$3.6 - $7.27 $77,630 - $156,770
-21,564 Closed
0 $0
Q1 2018

May 11, 2018

SELL
$3.39 - $4.39 $57,630 - $74,630
-17,000 Reduced 44.08%
21,564 $78,000
Q4 2017

Feb 13, 2018

SELL
$3.17 - $4.16 $7,925 - $10,400
-2,500 Reduced 6.09%
38,564 $150,000
Q3 2017

Nov 14, 2017

BUY
$3.03 - $3.97 $124,423 - $163,024
41,064
41,064 $156,000

Others Institutions Holding CSBR

About CHAMPIONS ONCOLOGY, INC.


  • Ticker CSBR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,522,400
  • Market Cap $62.7M
  • Description
  • Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Techn...
More about CSBR
Track This Portfolio

Track Shepherd Kaplan Krochuk, LLC Portfolio

Follow Shepherd Kaplan Krochuk, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shepherd Kaplan Krochuk, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Shepherd Kaplan Krochuk, LLC with notifications on news.